POZZI, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 14.510
AS - Asia 9.293
EU - Europa 6.518
SA - Sud America 1.069
Continente sconosciuto - Info sul continente non disponibili 949
AF - Africa 198
OC - Oceania 43
Totale 32.580
Nazione #
US - Stati Uniti d'America 13.785
SG - Singapore 2.708
VN - Vietnam 2.462
IT - Italia 2.135
CN - Cina 1.790
DE - Germania 966
HK - Hong Kong 897
RU - Federazione Russa 854
BR - Brasile 802
CA - Canada 561
SE - Svezia 557
GB - Regno Unito 406
IE - Irlanda 352
FR - Francia 263
IN - India 261
KR - Corea 215
BD - Bangladesh 192
FI - Finlandia 180
ID - Indonesia 138
AT - Austria 133
NL - Olanda 113
JP - Giappone 102
UA - Ucraina 102
AR - Argentina 98
TR - Turchia 96
IQ - Iraq 82
DK - Danimarca 75
LT - Lituania 75
ES - Italia 73
MX - Messico 65
PK - Pakistan 56
PL - Polonia 56
CH - Svizzera 52
ZA - Sudafrica 52
SA - Arabia Saudita 46
EC - Ecuador 41
AU - Australia 40
CO - Colombia 39
EG - Egitto 39
BE - Belgio 36
MY - Malesia 34
PH - Filippine 31
VE - Venezuela 30
JM - Giamaica 24
TW - Taiwan 23
PY - Paraguay 22
MA - Marocco 20
RO - Romania 20
IR - Iran 18
TH - Thailandia 18
AE - Emirati Arabi Uniti 17
CR - Costa Rica 16
ET - Etiopia 16
UZ - Uzbekistan 16
CL - Cile 15
HN - Honduras 15
CZ - Repubblica Ceca 13
KZ - Kazakistan 13
DZ - Algeria 12
JO - Giordania 12
OM - Oman 12
IL - Israele 11
TN - Tunisia 11
KE - Kenya 10
BO - Bolivia 9
PS - Palestinian Territory 9
UY - Uruguay 8
AO - Angola 7
BG - Bulgaria 7
EU - Europa 7
NI - Nicaragua 7
RS - Serbia 7
AZ - Azerbaigian 6
HR - Croazia 6
NG - Nigeria 6
NP - Nepal 6
SV - El Salvador 6
GT - Guatemala 5
HU - Ungheria 5
PA - Panama 5
TT - Trinidad e Tobago 5
AL - Albania 4
BN - Brunei Darussalam 4
GR - Grecia 4
KG - Kirghizistan 4
LV - Lettonia 4
LY - Libia 4
NO - Norvegia 4
PE - Perù 4
SN - Senegal 4
BB - Barbados 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
KW - Kuwait 3
MD - Moldavia 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
Totale 31.601
Città #
Ann Arbor 1.752
Singapore 1.620
Dallas 1.545
Ashburn 1.361
San Jose 1.280
Hong Kong 863
Milan 809
Ho Chi Minh City 744
Hanoi 593
Frankfurt am Main 569
Toronto 389
Los Angeles 383
Wilmington 351
Dublin 340
New York 340
Chandler 320
Council Bluffs 308
Santa Clara 255
Beijing 252
Dearborn 230
Chicago 207
Hefei 195
Seoul 177
Houston 165
Munich 165
Woodbridge 153
Boardman 147
Columbus 142
Rome 142
Princeton 136
The Dalles 131
Fairfield 130
Nanjing 119
Helsinki 115
Vienna 110
Buffalo 107
Jakarta 101
Seattle 97
Lauterbourg 93
Shanghai 92
Moscow 91
Jacksonville 86
São Paulo 86
Orem 82
Da Nang 81
Guangzhou 76
Phoenix 74
Haiphong 66
Tokyo 61
Vilnius 58
Denver 57
Ha Long 56
Atlanta 53
Hải Dương 53
Montreal 53
Brooklyn 52
Basingstoke 49
Chennai 49
Dong Ket 49
London 46
Biên Hòa 45
Warsaw 44
Amsterdam 43
Baghdad 43
Carate Brianza 38
Zurich 38
Ninh Bình 36
Pune 36
Rio de Janeiro 36
Bắc Ninh 35
Can Tho 35
Nuremberg 34
Quận Bình Thạnh 34
Poplar 33
Lawrence 32
Stockholm 32
Kent 31
Cambridge 30
Nanchang 30
Shenyang 30
Vũng Tàu 30
Altamura 28
San Francisco 28
Washington 28
Hangzhou 27
Melzo 27
Mexico City 26
Turku 26
Boston 25
Manchester 25
Thái Nguyên 25
Florence 24
Bắc Giang 23
Sacramento 23
Figino 22
Johannesburg 22
Ottawa 22
Turin 22
Baltimore 21
Brussels 21
Totale 19.516
Nome #
CIPN and its mechanism of development 682
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 605
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 541
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 496
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 489
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 479
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 475
OXALIPLATIN-INDUCED PERIPHERAL NEUROTOXICITY IN MOUSE MODELS: DIFFERENT TREATMENT SCHEDULES AND FOCUS ON OXIDATIVE STRESS 462
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 460
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 454
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 448
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 440
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 435
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 431
Ion Channel and Transporter Involvement in Chemotherapy-Induced Peripheral Neurotoxicity 423
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 422
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 422
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 411
Investigation of Supraspinal Plasticity in a Rat Model of Painful Paclitaxel-induced Peripheral Neuropathy 405
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 404
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 394
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 378
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 375
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 368
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 360
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 354
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 353
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 351
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 350
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 348
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 348
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 346
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 342
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 334
EVALUATION OF SATELLITE GLIAL CELLS CHANGES IN DORSAL ROOT GANGLIA IN CHEMOTHERAPY-INDUCED NEUROTOXICITY MODELS 331
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 329
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 325
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 324
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 323
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 323
In vivo study of Carfilzomib-Induced Neuropathy 322
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 309
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 307
Paclitaxel alters angiogenesis in the peripheral and central nervous system of neuropathic rats 304
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 301
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 301
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 301
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 296
Multimodal experimental approach to the study of human neurological diseases 296
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 295
Central and peripheral neoangiogenesis in paclitaxel-induced painful peripheral neuropathy 295
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 291
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 290
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 287
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 286
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 284
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 282
The relevance of morphology in experimental oxaliplatin-induced peripheral neurotoxicity 275
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 271
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 269
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity 268
Genetic factors influencing the development of vincristine-induced neurotoxicity 268
Oxaliplatin neurotoxicity: morpho-functional approach 266
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 258
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 254
Peripheral neurotoxicity induced by cisplatin: a possible role of OCT2 gene 254
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 247
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 246
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 245
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 239
Acute and chronic Oxaliplatin-induced peripheral neurotoxicity: two sides of the same coin 238
Metabolomics assessment in a mice model ofoxaliplatin-induced peripheral neurotoxicity 238
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 237
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 237
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 233
ERIBULIN, PACLITAXEL, IXABEPILONE AND VINORELBINE-INDUCED PERIPHERAL NEUROPATHY IN MICE: INSIGHTS IN LONG-TERM RECOVERY 231
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 229
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 229
High resolution MRI in exploring peripheral nerve anatomy and axonal damage in rodent models 227
INVESTIGATION OF AGING EFFECTS ON NERVE DAMAGE IN AN ANIMAL MODEL OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY 223
The severity of oxaliplatin neurotoxicity is related to differential expression of a solute transporter in mice 218
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 216
Refinement Of Dorsal Root Ganglia Neurons Morphometry 214
Oxaliplatin Neurotoxicity is related to SLC4A1 Expression in BALB/c Mice Dorsal Root Ganglia 211
Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN) 199
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 198
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 197
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 191
REFINEMENT OF MORPHOLOGICAL ANALYSIS OF THE CAUDAL NERVE IN A RODENT MODEL OF AXONAL DAMAGE WITH 7T MRI 190
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 188
MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN 187
Oxaliplatin-Induced Peripheral Neurotoxicity: a Role for Genomics? 183
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 182
THYMOQUINONE AS A POSSIBLE NEUROPROTECTIVE AGENT AGAINST PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 181
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 180
Investigation of Supraspinal Plasticity of Painful Paclitaxel-Induced Peripheral Neuropathy 180
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 175
Can different Mice Strains be differently susceptible to Oxaliplatin-Induced Peripheral Neuropathy? 167
New mechanisms of neurotoxicity related to oxaliplatin chemotherapy in mice 162
Interleukin-6 as a keystone cytokine in experimental rat models of chemotherapy-induced peripheral neurotoxicity 156
Totale 30.844
Categoria #
all - tutte 96.571
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.571


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022752 0 0 0 97 93 104 49 49 44 52 79 185
2022/20231.860 187 364 234 172 163 300 63 75 135 41 82 44
2023/20241.550 68 61 70 92 156 356 242 104 77 39 47 238
2024/20255.175 239 500 470 235 401 282 434 186 577 708 406 737
2025/202614.780 2.206 1.468 1.975 1.298 1.163 669 1.721 641 983 1.102 745 809
2026/20273.490 775 510 1.396 809 0 0 0 0 0 0 0 0
Totale 32.580